BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/9/2022 4:16:50 AM | Browse: 210 | Download: 571
Publication Name World Journal of Experimental Medicine
Manuscript ID 80740
Country India
Received
2022-10-10 18:26
Peer-Review Started
2022-10-10 18:28
To Make the First Decision
Return for Revision
2022-11-11 09:43
Revised
2022-11-18 05:07
Second Decision
2022-12-07 03:23
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-12-07 18:36
Articles in Press
2022-12-07 18:36
Publication Fee Transferred
Edit the Manuscript by Language Editor
2022-12-01 09:19
Typeset the Manuscript
2022-12-09 02:15
Publish the Manuscript Online
2022-12-09 04:16
ISSN 2220-315x (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Rheumatology
Manuscript Type Letter to the Editor
Article Title Can hydroxychloroquine be used for COVID-19-induced arthritis? A debatable hypothesis
Manuscript Source Unsolicited Manuscript
All Author List Raktim Swarnakar, Sankha Subhra Roy and Shiv Lal Yadav
ORCID
Author(s) ORCID Number
Raktim Swarnakar http://orcid.org/0000-0002-7221-2825
Funding Agency and Grant Number
Corresponding Author Raktim Swarnakar, MBBS, MD, Doctor, Department of Physical Medicine and Rehabilitation, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, Delhi, India. raktimswarnakar@hotmail.com
Key Words COVID-19; Arthritis; Hydroxychloroquine; DMARDS; SARS-CoV-2; Post-COVID-19 arthritis
Core Tip Hydroxychloroquine is a known disease-modifying antirheumatic drug and has antiviral properties. It had previously been used to treat viral arthritis. In this letter, using future research questions in the context of the evidence in the literature we debate whether hydroxychloroquine can be used in post-coronavirus disease 2019 arthritis.
Publish Date 2022-12-09 04:16
Citation Swarnakar R, Roy SS, Yadav SL. Can hydroxychloroquine be used for COVID-19-induced arthritis? A debatable hypothesis. World J Exp Med 2022; 12(6): 108-110
URL https://www.wjgnet.com/2220-315x/full/v12/i6/108.htm
DOI https://dx.doi.org/10.5493/wjem.v12.i6.108
Full Article (PDF) WJEM-12-108.pdf
Full Article (Word) WJEM-12-108.docx
Manuscript File 80740_Auto_Edited-LM.docx
Answering Reviewers 80740-Answering reviewers.pdf
Audio Core Tip 80740-Audio core tip.aac
Conflict-of-Interest Disclosure Form 80740-Conflict-of-interest statement.pdf
Copyright License Agreement 80740-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 80740-Language certificate.pdf
Peer-review Report 80740-Peer-review(s).pdf
Scientific Misconduct Check 80740-Bing-Liu JH-2.jpg
Scientific Misconduct Check 80740-CrossCheck.jpg
Scientific Editor Work List 80740-Scientific editor work list.pdf